Article
The role of N-glycosylation sites on the CXCR4 receptor for CXCL-12 binding and signaling and X4 HIV-1 viral infectivity.
Virology - 5 Jul 2007
Huskens Dana, Princen Katrien, Schreiber Michael, Schols Dominique
Abstract excerpt
The chemokine receptor CXCR4 functions as one of the HIV-1 coreceptors and can be considered as an attractive target for the development of novel anti-HIV drugs. Here, we investigated the effect of its two known N-glycosylation sites g1 (NYT) and g2 (NVS) on the antiviral potential of several classes of entry inhibitors. The lack of g1 clearly affected the binding of the amino-terminal directed 2B11 mAb, but not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
